Live Breaking News & Updates on Rapid Abstract

Stay updated with breaking news from Rapid abstract. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Deciphera Pharmaceuticals to Present Data from INTRIGUE Phase 3 Study of QINLOCK® (ripretinib) and Trial-in-Progress Poster for INSIGHT Pivotal Phase 3 Study of QINLOCK® at the 2023 American Society of Clinical Oncology Annual Meeting

– Company Presents Poster on Overall Survival and Long-Term Safety Results from INTRIGUE Study; Second Poster Presents Analysis from INTRIGUE Patients without Detectable ctDNA at Baseline. | May 25, 2023 ....

Germany , Australia , Israel , Hong-kong , Switzerland , Chicago , Illinois , United-states , Macau , United-kingdom , Canada , Taiwan